miR-1226 can directly target the 3′ UTR of MUC1 mRNA and downregulate endogenous MUC1 protein levels in human breast cancer cell lines, which can increase ROS, lower the mitochondrial transmembrane potential, and ultimately decrease cell survival. This evidence concerns the gene MUC1 and breast cancer.